All Stories

  1. Bruton's tyrosine kinase is a potential therapeutic target of Graves' orbitopathy (GO)

    Article • PLoS ONE, December 2022, PLOS

    Hyun Young Park

  2. Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves’ orbitopathy

    Article • PLoS ONE, August 2021, PLOS

    Hyun Young Park

  3. Protein tyrosine phosphatase 1B as a therapeutic target for Graves’ orbitopathy in an in vitro model

    Article • PLoS ONE, August 2020, PLOS

    Hyun Young Park

  4. MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves’ orbitopathy

    Article • PLoS ONE, August 2019, PLOS

    Hyun Young Park

  5. Proinflammatory Effects of Calprotectin in Graves’ Orbitopathy

    Article • Ocular Immunology and Inflammation, November 2018, Taylor & Francis

    Hyun Young Park